Logo image of JST.DE

JOST WERKE SE (JST.DE) Stock Earnings & Estimates

Europe - Frankfurt Stock Exchange - FRA:JST - DE000JST4000 - Common Stock

60.9 EUR
+1.8 (+3.05%)
Last: 1/15/2026, 5:29:57 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
JST.DE revenue by date.JST.DE revenue by date.
1.265B
20.33%
1.25B
-1.18%
1.069B
-14.43%
1.532B
43.26%
1.684B
9.92%
1.763B
4.69%
2.117B
20.08%
2.191B
3.50%
2.062B
-5.89%
2.313B
12.17%
2.359B
1.99%
EBITDA
YoY % growth
JST.DE ebitda by date.JST.DE ebitda by date.
138.004M
20.67%
144.25M
4.53%
124.881M
-13.43%
195.09M
56.22%
222M
13.79%
239.59M
7.92%
244.95M
2.24%
N/AN/AN/AN/A
EBIT
YoY % growth
JST.DE ebit by date.JST.DE ebit by date.
80.075M
69.82%
86.254M
7.72%
64.972M
-24.67%
116.25M
78.92%
159.94M
37.58%
176.35M
10.26%
N/AN/AN/AN/AN/A
Operating Margin
JST.DE operating margin by date.JST.DE operating margin by date.
6.33%6.90%6.08%7.59%9.50%10.00%N/AN/AN/AN/AN/A
EPS
YoY % growth
JST.DE eps by date.JST.DE eps by date.
N/A
16.06%
N/A
9.44%
5.21
-16.06%
5.51
5.77%
6.97
26.47%
7.82
12.17%
N/AN/AN/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.11
13.27%
1.48-0.37-25.24%
Q2 2025
Q2Q % growth
1.41
2.92%
1.61-0.20-12.20%
Q4 2024
Q2Q % growth
1.16
17.17%
1.47-0.31-21.33%
Q3 2024
Q2Q % growth
0.98
7.69%
1.37-0.39-28.65%
Q2 2024
Q2Q % growth
1.37
-2.14%
1.010.3635.64%
Q1 2024
Q2Q % growth
1.70 1.010.6968.32%
Q4 2023
Q2Q % growth
0.99
-12.39%
1.13-0.14-12.09%
Q3 2023
Q2Q % growth
0.91
-2.15%
1.39-0.48-34.71%
Q2 2023
Q2Q % growth
1.40 1.79-0.39-21.69%
Q4 2022
Q2Q % growth
1.13
-68.48%
0.760.3749.17%
Q3 2022
Q2Q % growth
0.93 0.99-0.06-6.04%
Q4 2021
Q2Q % growth

167.57%
3.59%
Q4 2020
Q2Q % growth
1.34 0.570.77136.92%
Q3 2020
Q2Q % growth
0.79 0.400.3998.02%
Q2 2020
Q2Q % growth
0.66 0.130.53402.67%
JST.DE Yearly EPS VS EstimatesJST.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
383.2M
55.61%
382.59M610K0.16%
Q2 2025
Q2Q % growth
390.7M
31.03%
420.46M-29.76M-7.08%
Q1 2025
Q2Q % growth
373.702M
25.17%
%
Q4 2024
Q2Q % growth
226.419M
-20.74%
228.23M-1.811M-0.79%
Q3 2024
Q2Q % growth
246.263M
-15.67%
264.49M-18.227M-6.89%
Q2 2024
Q2Q % growth
298.173M
-9.75%
301.38M-3.207M-1.06%
Q1 2024
Q2Q % growth
298.545M
-12.61%
308.25M-9.705M-3.15%
Q4 2023
Q2Q % growth
285.655M
-5.94%
297.32M-11.665M-3.92%
Q3 2023
Q2Q % growth
292.024M
-10.73%
317.52M-25.496M-8.03%
Q2 2023
Q2Q % growth
330.4M
2.60%
337.19M-6.79M-2.01%
Q1 2023
Q2Q % growth
341.616M
9.57%
%
Q4 2022
Q2Q % growth
303.68M
14.13%
309.26M-5.58M-1.80%
Q3 2022
Q2Q % growth
327.126M
29.90%
299.26M27.866M9.31%
Q2 2022
Q2Q % growth
322.026M
16.81%
%
Q1 2022
Q2Q % growth
311.774M
21.15%
%
Q4 2021
Q2Q % growth
266.087M
15.28%
847.751M-581.664M-68.61%
Q3 2021
Q2Q % growth
251.828M
27.88%
%
Q2 2021
Q2Q % growth
275.675M
57.65%
%
Q1 2021
Q2Q % growth
257.341M
34.17%
232.3M25.041M10.78%
Q4 2020
Q2Q % growth
230.809M 233.11M-2.301M-0.99%
Q3 2020
Q2Q % growth
196.927M 188.67M8.257M4.38%
Q2 2020
Q2Q % growth
174.869M 163.12M11.749M7.20%
JST.DE Yearly Revenue VS EstimatesJST.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% -4.15%
RevenueN/A N/A 0% -0.71%